A revisited strategy for antiepileptic drug development in children: Designing an initial exploratory step

CNS Drugs

Volumn 27, Issue 3, 2013, Pages 185-195

  Chiron, Catherine ^a,b   Kassai, Behrouz ^c   Dulac, Olivier ^a,b   Pons, Gerard ^a,b,d   Nabbout, Rima ^a,b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d University Hospital of Lyon ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

CHILDHOOD ABSENCE EPILEPSY; CLINICAL TRIAL; COHORT ANALYSIS; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPTIC ENCEPHALOPATHY; GENERALIZED EPILEPSY; HUMAN; INFANTILE SPASM; LENNOX GASTAUT SYNDROME; PEDIATRICS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SEVERE MYOCLONIC EPILEPSY IN INFANCY;

ADULT; ANTICONVULSANTS; CHILD; DRUG DESIGN; EPILEPSIES, PARTIAL; EPILEPSY; HUMANS; INTELLECTUAL DISABILITY; OFF-LABEL USE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SPASMS, INFANTILE;

EID: 84876709923     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.1007/s40263-012-0035-9     Document Type: Review

References (44)

1. Rheims S, Cucherat M, Arzimanoglou A, et al. Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy. PLoS Med. 2008;5(8):e166.
2. Bosch X. Pediatric medicine: Europe follows U.S. in testing drugs for children [letter]. Science. 2005;309(5742):1799.
3. Chiron C, Dulac O, Pons G. Antiepileptic drug development in children: considerations for a revisited strategy. Drugs. 2008;68(1):17-25.
4. Chiron C, Dumas C, Jambaque I, et al. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res. 1997;26(2):389-95.
5. Appleton RE, Peters AC, Mumford JP, et al. Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia. 1999;40(11):1627-33.
6. Elterman RD, Shields WD, Mansfield KA, et al. Randomized trial of vigabatrin in patients with infantile spasms. Neurology. 2001;57(8):1416-21.
7. Chiron C, Marchand MC, Tran A, et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet. 2000;356(9242):1638-42.
8. Chiron C, Dulac O, Beaumont D, et al. Therapeutic trial of vigabatrin in refractory infantile spasms. J Child Neurol 1991;Suppl. 2:S52-S59.
9. Perez J, Chiron C, Musial C, et al. Stiripentol: efficacy and tolerability in children with epilepsy. Epilepsia. 1999;40(11):1618-26.
10. Besag FM, Wallace SJ, Dulac O, et al. Lamotrigine for the treatment of epilepsy in childhood. J Pediatr. 1995;127(6):991-7.
11. Duchowny M, Pellock JM, Graf WD, et al. A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children: Lamictal Pediatric Partial Seizure Study Group. Neurology. 1999;53(8):1724-31.
12. Dulac O, Chiron C, Luna D, et al. Vigabatrin in childhood epilepsy. J Child Neurol 1991;Suppl. 2:S30-S37.
13. Frank LM, Enlow T, Holmes GL, et al. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia. 1999;40(7):973-9.
14. Motte J, Trevathan E, Arvidsson JF, et al. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome: Lamictal Lennox-Gastaut Study Group. N Engl J Med. 1997;337(25):1807-12.
15. Schlumberger E, Chavez F, Palacios L, et al. Lamotrigine in treatment of 120 children with epilepsy. Epilepsia. 1994;35(2):359-67.
16. Chiron C, Dulac O, Gram L. Vigabatrin withdrawal randomized study in children. Epilepsy Res. 1996;25(3):209-15.
17. Eriksson AS, Nergardh A, Hoppu K. The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, crossover study. Epilepsia. 1998;39(5):495-501.
18. Farrell K, Connolly MB, Munn R, et al. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy. Pediatr Neurol. 1997;16(3):201-5.
19. Glauser TA, Ayala R, Elterman RD, et al. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology. 2006;66(11):1654-60.
20. Glauser T, Kluger G, Sachdeo R, et al. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology. 2008;70(21):1950-8.
21. Pina-Garza JE, Nordli DR Jr, Rating D, et al. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures. Epilepsia. 2009;50(5):1141-9.
22. Oguni H, Hayashi K, Fukuyama Y. Phase III clinical study of the new antiepileptic drug AD-810, zonisamide, in childhood epilepsy. Jpn J Pediatr. 1988;41:439-50.
23. Chhun S, Troude P, Villeneuve N, et al. A prospective open-labeled trial with levetiracetam in pediatric epilepsy syndromes: continuous spikes and waves during sleep is definitely a target. Seizure. 2011;20(4):320-5.
24. Mikaeloff Y, Saint-Martin A, Mancini J, et al. Topiramate: efficacy and tolerability in children according to epilepsy syndromes. Epilepsy Res. 2003;53(3):225-32.
25. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989;30(4):389-99.
26. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010;51(4):676-85.
27. Appleton R, Fichtner K, LaMoreaux L, et al. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group. Epilepsia. 1999;40(8):1147-54.
28. Elterman RD, Glauser TA, Wyllie E, et al. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children: Topiramate YP Study Group. Neurology. 1999;52(7):1338-44.
29. Glauser TA, Nigro M, Sachdeo R, et al. Adjunctive therapy with oxcarbazepine in children with partial seizures: the Oxcarbazepine Pediatric Study Group. Neurology. 2000;54(12):2237-44.
30. Uthman BM, Rowan AJ, Ahmann PA, et al. Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial. Arch Neurol. 1998;55(1):56-62.
31. Pina-Garza JE, Espinoza R, Nordli DR, et al. Oxcarbazepine adjunctive therapy in infants and young children with partial seizures. Neurology. 2005;65(9):1370-5.
32. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome): the Felbamate Study Group in Lennox-Gastaut Syndrome. N Engl J Med 1993;328(1):29-33.
33. Sachdeo RC, Glauser TA, Ritter F, et al. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome: Topiramate YL Study Group. Neurology. 1999;52(9):1882-7.
34. Richens A, Chadwick DW, Duncan JS, et al. Adjunctive treatment of partial seizures with tiagabine: a placebo-controlled trial. Epilepsy Res. 1995;21(1):37-42.
35. Glauser TA. Preliminary observations on topiramate in pediatric epilepsies. Epilepsia. 1997;38(Suppl. 1):S37-41.
36. Tiagabine Shinnar S. Semin Pediatr Neurol. 1997;4(1):24-33.
37. Avanzini G, Canger R, Dalla BB, et al. Felbamate in therapy-resistant epilepsy: an Italian experience. Felbamate Italian Study Group. Epilepsy Res. 1996;25(3):249-55.
38. Grosso S, Franzoni E, Coppola G, et al. Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy. Seizure. 2005;14(4):248-53.
39. Uldall P, Bulteau C, Pedersen SA, et al. Tiagabine adjunctive therapy in children with refractory epilepsy: a single-blind dose escalating study. Epilepsy Res. 2000;42(2-3):159-68.
40. Yagi K. Overview of Japanese experience-controlled and uncontrolled trials. Seizure. 2004;13(Suppl. 1):S11-5.
41. Craig JC, Webster AC, Mitchell A, et al. Expanding the evidence base in transplantation: more and better randomized trials, and extending the value of observational data. Transplantation. 2008;86(1):32-5.
42. Klassen TP, Hartling L, Craig JC, et al. Children are not just small adults: the urgent need for high-quality trial evidence in children. PLoS Med. 2008;5(8):e172.
43. Chiron C, Tonnelier S, Rey E, et al. Stiripentol in childhood partial epilepsy: randomized placebo-controlled trial with enrichment and withdrawal design. J Child Neurol. 2006;21:496-502.
44. Kassaï B, Chiron C, Augier S, et al. Severe myoclonic epilepsy in infancy: a systematic review and a meta-analysis of individual patient data. Epilepsia. 2008;49(2):343-8.